Cargando…

35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients

Detalles Bibliográficos
Autores principales:	Baker, Mairead, Russomanno, Kristen, Raiker, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465210/ http://dx.doi.org/10.1016/j.jaad.2022.06.456

Ejemplares similares

35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients
por: Pakhchanian, Haig, et al.
Publicado: (2022)

35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis
por: Baker, Mairead, et al.
Publicado: (2022)

262 Safety and efficacy of the COVID-19 vaccine among fully vaccinated and boosted skin cancer patients
por: Raiker, R., et al.
Publicado: (2022)

254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients
por: Raiker, R., et al.
Publicado: (2021)

LB766 Prevalence and adverse events of special interest among COVID19-vaccinated patients with chronic inflammatory skin diseases: An early look
por: Raiker, R., et al.
Publicado: (2021)

LB768 Adult and pediatric emergency department visits for dermatological conditions during the COVID-19 pandemic: A multicenter analysis
por: Pakhchanian, H., et al.
Publicado: (2021)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
por: Potestio, Luca, et al.
Publicado: (2023)

265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
por: Pakhchanian, H., et al.
Publicado: (2022)

Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
por: Lopez, Erick Daniel, et al.
Publicado: (2021)

COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
por: Pakhchanian, Haig, et al.
Publicado: (2022)

COVID-19 among patients with Behçet syndrome in the United States
por: Pakhchanian, Haig, et al.
Publicado: (2021)

Efficacy and safety of COVID‐19 vaccines
por: Graña, Carolina, et al.
Publicado: (2022)

Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
por: Huang, He, et al.
Publicado: (2023)

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022)

Burden of Thrombotic Events in Coronavirus Disease-19 (COVID-19) Patients and Effect on Outcomes (from a Multicenter Electronic Health Record Database)
por: Mukherjee, Amrita, et al.
Publicado: (2021)

JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
por: Hsu, Leeyen, et al.
Publicado: (2014)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
por: Kelly, Hannah, et al.
Publicado: (2021)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Efficacy and Safety of COVID-19 Vaccines—An Update
por: Sharma, Eshani, et al.
Publicado: (2022)

A systematic review on the efficacy and safety of Infliximab in patients with psoriasis
por: Wang, Jin, et al.
Publicado: (2015)

Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski, Christina
Publicado: (2015)

Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
por: Abrouk, Michael, et al.
Publicado: (2016)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

LB767 A multicenter analysis of patients using telemedicine for dermatological conditions during the COVID-19 pandemic
por: Raiker, R., et al.
Publicado: (2021)

Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer
por: Couderc, Anne-Laure, et al.
Publicado: (2022)

Efficacy and Safety of COVID-19 Vaccine in Patients on Renal Replacement Therapy
por: Frittoli, Michela, et al.
Publicado: (2022)

Psoriasis—a Possible Candidate for Vaccination
por: Fry, Lionel, et al.
Publicado: (2006)

The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis
por: Jenneck, Claudia, et al.
Publicado: (2007)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik, Benjamin, et al.
Publicado: (2016)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Halle, Briana Rose, et al.
Publicado: (2021)

COVID-19’s impact on interest in gastrointestinal topics
por: Yan, Michael B., et al.
Publicado: (2022)

Safety and Efficacy of the Common Vaccines against COVID-19
por: Liu, Ying, et al.
Publicado: (2022)

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
por: Okubo, Yukari, et al.
Publicado: (2022)

31047 Erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine
por: Pabón-Cartagena, Gabriela, et al.
Publicado: (2022)

Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study
por: Asahina, Akihiko, et al.
Publicado: (2016)

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
por: Cai, Changjing, et al.
Publicado: (2021)

Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends
por: Kardeş, Sinan, et al.
Publicado: (2020)

Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
por: Raiker, Rahul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3gmjo324ij9t5iqq8ie5jbnr9